Advancing Health Equity in Pharma: Key Themes from the 2024 WOCIP Cluster Meetings

Clarkston Consulting recently sponsored and attended this year’s 2024 Women of Color in Pharma (WOCIP) Cluster meetings, which focused, with intention, on WOCIP’s priority of addressing health equity. The four-day event brought together industry leaders across clinical, external affairs, employee resource groups, and executives to discuss and strategize around advancing health equity in pharma.

At the cluster meetings, a number of key themes were covered – the importance of humanizing individuals and building connections; distinguishing health equity from diversity, equity, and inclusion by focusing on access to health and addressing disparities in healthcare; and establishing a framework for addressing health equity that includes individual responsibility, organizational leadership, community engagement, and ecosystem impact.

Based on a survey gathered from respondents, the main takeaway from the Cluster was that a large majority (78%) of participants believe there’s a gap between industry commitment to health equity and real-world results, and most (52%) would agree that ​biopharma companies should prioritize building public trust to advance health equity​.  

READ FULL ARTICLE